wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41002305-0A1F217E-E241-4CA5-B9A2-E0C3BE20F31E
Q41002305-0A1F217E-E241-4CA5-B9A2-E0C3BE20F31E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41002305-0A1F217E-E241-4CA5-B9A2-E0C3BE20F31E
Photosensitivity reactions to vandetanib: redevelopment after sequential treatment with docetaxel.
P2860
Q41002305-0A1F217E-E241-4CA5-B9A2-E0C3BE20F31E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41002305-0A1F217E-E241-4CA5-B9A2-E0C3BE20F31E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd02f12fb5ffc7a6ae74b9ee33633688771f0465
P2860
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.